Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial

Tunde Peto, Maartje J.C. Vader, A. nn-Sofie M.E. Schauwvlieghe, Frank D Verbraak, Greetje Dijkman, Johanna M.M. Hooymans, Leonoor I. Los, Aeilko H. Zwinderman, Tunde Peto, Carel B Hoyng, Redmer van Leeuwenhoek, Johannes R. Vingerling, Yvonne de Jong-Hesse, Janneke J.C. van Lith-Verhoeven, Marcel G.W. Dijkgraaf, Reinier O. Schlingemann

Research output: Contribution to journalArticle

Original languageEnglish
JournalOpthalmology Retina
Early online date07 Jan 2020
DOIs
Publication statusEarly online date - 07 Jan 2020

Cite this

Peto, T., Vader, M. J. C., Schauwvlieghe, A. N-S. M. E., Verbraak, F. D., Dijkman, G., Hooymans, J. M. M., ... Schlingemann, R. O. (2020). Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial. Opthalmology Retina. https://doi.org/10.1016/j.oret.2019.12.019
Peto, Tunde ; Vader, Maartje J.C. ; Schauwvlieghe, A. nn-Sofie M.E. ; Verbraak, Frank D ; Dijkman, Greetje ; Hooymans, Johanna M.M. ; Los, Leonoor I. ; Zwinderman, Aeilko H. ; Peto, Tunde ; Hoyng, Carel B ; Leeuwenhoek, Redmer van ; Vingerling, Johannes R. ; Jong-Hesse, Yvonne de ; Lith-Verhoeven, Janneke J.C. van ; Dijkgraaf, Marcel G.W. ; Schlingemann, Reinier O. . / Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial. In: Opthalmology Retina. 2020.
@article{2162d07547454f2a9c690e4031b70a46,
title = "Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial",
author = "Tunde Peto and Vader, {Maartje J.C.} and Schauwvlieghe, {A. nn-Sofie M.E.} and Verbraak, {Frank D} and Greetje Dijkman and Hooymans, {Johanna M.M.} and Los, {Leonoor I.} and Zwinderman, {Aeilko H.} and Tunde Peto and Hoyng, {Carel B} and Leeuwenhoek, {Redmer van} and Vingerling, {Johannes R.} and Jong-Hesse, {Yvonne de} and Lith-Verhoeven, {Janneke J.C. van} and Dijkgraaf, {Marcel G.W.} and Schlingemann, {Reinier O.}",
year = "2020",
month = "1",
day = "7",
doi = "10.1016/j.oret.2019.12.019",
language = "English",
journal = "Opthalmology Retina",
issn = "2468-6530",
publisher = "Elsevier Inc.",

}

Peto, T, Vader, MJC, Schauwvlieghe, AN-SME, Verbraak, FD, Dijkman, G, Hooymans, JMM, Los, LI, Zwinderman, AH, Peto, T, Hoyng, CB, Leeuwenhoek, RV, Vingerling, JR, Jong-Hesse, YD, Lith-Verhoeven, JJCV, Dijkgraaf, MGW & Schlingemann, RO 2020, 'Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial', Opthalmology Retina. https://doi.org/10.1016/j.oret.2019.12.019

Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial. / Peto, Tunde; Vader, Maartje J.C.; Schauwvlieghe, A. nn-Sofie M.E. ; Verbraak, Frank D; Dijkman, Greetje ; Hooymans, Johanna M.M.; Los, Leonoor I. ; Zwinderman, Aeilko H.; Peto, Tunde; Hoyng, Carel B; Leeuwenhoek, Redmer van ; Vingerling, Johannes R.; Jong-Hesse, Yvonne de ; Lith-Verhoeven, Janneke J.C. van ; Dijkgraaf, Marcel G.W. ; Schlingemann, Reinier O. .

In: Opthalmology Retina, 07.01.2020.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial

AU - Peto, Tunde

AU - Vader, Maartje J.C.

AU - Schauwvlieghe, A. nn-Sofie M.E.

AU - Verbraak, Frank D

AU - Dijkman, Greetje

AU - Hooymans, Johanna M.M.

AU - Los, Leonoor I.

AU - Zwinderman, Aeilko H.

AU - Peto, Tunde

AU - Hoyng, Carel B

AU - Leeuwenhoek, Redmer van

AU - Vingerling, Johannes R.

AU - Jong-Hesse, Yvonne de

AU - Lith-Verhoeven, Janneke J.C. van

AU - Dijkgraaf, Marcel G.W.

AU - Schlingemann, Reinier O.

PY - 2020/1/7

Y1 - 2020/1/7

U2 - 10.1016/j.oret.2019.12.019

DO - 10.1016/j.oret.2019.12.019

M3 - Article

JO - Opthalmology Retina

JF - Opthalmology Retina

SN - 2468-6530

ER -